The importance of Alzheimer disease assessment scale-cognitive part in predicting progress for amnestic mild cognitive impairment to Alzheimer disease

Journal of Geriatric Psychiatry and Neurology

Volumn 21, Issue 4, 2008, Pages 261-267

  Rozzini, Luca ^a,b   Vicini Chilovi, Barbara ^a,b   Bertoletti, Erik ^a   Conti, Marta ^a   Delrio, Ilenia ^a   Trabucchi, Marco ^b   Padovani, Alessandro ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b GERIATRIC RESEARCH GROUP   (Italy)

Author keywords

AD; ADAS Cog; Alzheimer disease; Alzheimer Disease Assessment Scale cognitive part; Dementia; MCI; Mild cognitive impairment

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SENESCENCE;

AGED; ALZHEIMER DISEASE; COGNITION DISORDERS; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY DISORDERS; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 55949104627     PISSN: 08919887     EISSN: 15525708     Source Type: Journal    
DOI: 10.1177/0891988708324940     Document Type: Article

References (41)

1. Morris J., Storandt M., Miller JP, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol. 2001 ; 58: 397-405.
2. Larrieu S., Letenneur L., Orgogozo JM, et al. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology. 2002 ; 59: 1594-1599.
3. Artero S., Tierney MC, Touchon J., Ritchie K. Prediction of transition from cognitive impairment to senile dementia: a prospective, longitudinal study. Acta Psychiatr Scand. 2003 ; 107: 390-393.
4. Tuokko H., Frerichs R., Graham J., et al. Five-year follow-up of cognitive impairment with no dementia. Arch Neurol. 2003 ; 60: 577-582.
5. Busse A., BischKopf J., Riedel-Heller SG, Angermeyer MC Mild cognitive impairment: prevalence and incidence according to different diagnostic criteria. Results of the Leipzig Longitudinal Study of the Aged (LEILA75 +). Br J Psychiatry. 2003 ; 182: 449-454.
6. Petersen RC Challenges of epidemiological studies of mild cognitive impairment. Alzheimer Dis Assoc Disord. 2004 ; 18: 1-2.
7. Grundman M., Petersen RC, Ferris SH, et al. Mild Cognitive Impairment can be distinguished from Alzheimer Disease and Normal Aging for clinical trials. Arch Neurol. 2004 ; 61: 59-66.
8. Petersen RC, Doody R., Kurz A., et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001 ; 58: 1985-1992.
9. Petersen RC, Thomas RG, Grundman M., et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005 ; 352: 2379-2388.
10. Alexopoulos P., Grimmer T., Perneczky R., Domes G., Kurz A. Progression to dementia in clinical subtypes of mild cognitive impairment. Dement Geriatr Cogn Disord. 2006 ; 22: 27-34.
11. Gabryelewicz T., Styczynska M., Luczywek E., et al. The rate of conversion of mild cognitive impairment to dementia: predictive role of depression. Int J Geriatr Psychiatry. 2007 ; 22: 563-567.
12. Yaffe K., Petersen RC, Lindquist K., Kramer J., Miller B. Subtype of mild cognitive impairment and progression to dementia and death. Dement Geriatr Cogn Disord. 2006 ; 22: 312-319.
13. Tabert MH, Manly JJ, Liu X., et al. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry. 2006 ; 63: 916-924.
14. Perri R., Serra L., Carlesimo GA, et al. Preclinical Dementia: An Italian Multicentre Study on Amnestic Mild Cognitive Impairment. Dement Geriatr Cogn Disord. 2007 ; 23: 289-300.
15. Fleisher AS, Sowell BB, Taylor C., et al. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology. 2007 ; 68: 1588-1595.
16. Fioravanti M., Nacca D., Buckley AE, et al. The Italian version of the Alzheimer's disease Assessment Scale, ADAS: Psychometric and normative characteristics from a normal aged population. Arch Gerontol Geriatr. 1994 ; 19: 21-30.
17. Novelli G., Papagno C., Capitani E., Laiacona M., Vallar G., Cappa SF Tre tests clinici di ricerca e produzione lessicale. Taratura su soggetti normali. Arch Psicol Neurol Psichiatr. 1986 ; 4: 477-506.
18. Huges CP, Berg L., Danziger WL, Coben LA, Martin RL A new clinical scale for the staging of dementia. Br J Psychiatry. 1982 ; 140: 566-572.
19. Folstein MF, Folstein SE, McHugh PR ''Mini-mental State'': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 ; 12: 189-198.
20. Artero S., Petersen R., Touchon J., Ritchie K. Revised criteria for mild cognitive impairment: validation within a longitudinal population study. Dement Geriatr Cogn Disord. 2006 ; 22: 465-470.
21. Lawton MP, Brody EM Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969 ; 9: 179-186.
22. Katz S., Downs TD, Cash HR, Grotz RC Progress in development of the index ofADL. Gerontologist. 1970 ; 10: 20-30.
23. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan EM Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 ; 34: 939-944.
24. Cummings JL, Mega M., Gray K., Rosenberg-Thompson S., Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994 ; 44: 2308-2314.
25. Rey A. L'examen Clinique En Psychologie. Paris: Press Universitaire de France ; 1964.
26. Bingham WC, Burke HR, Murray S. Raven's progressive matrices: construct validity. J Psychol. 1966 ; 62: 205-209.
27. Reitan RM Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot skills. 1958 ; 8: 271-276.
28. Osterrieth PA Le test de copie d' une figure complex: contribution a l' étude de la perception et la mémorie. Arch Psychol. 1944 ; 30: 286-356.
29. Benton AL, Hamsher K. Multilingua Aphasia Examination. Iowa City, IA: AJA Associates ; 1983.
30. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. ed. 4 Washington, DC: American Psychiatric Association ; 1994.
31. Statistical Package for the Social Sciences for Windows, Release 11.5.1 (Italian version). Chicago, IL: SPSS Inc ; 2002.
32. Rozzini L., Chilovi BV, Trabucchi M., Padovani A. Impaired financial abilities in mild cognitive impairment: a direct assessment approach. Neurology. 2003 ; 60: 2021.
33. Bruscoli M., Lovenstone S. Is MCI just early dementia? A systematic review of conversion studies. Int Psychogeriatr. 2004 ; 16: 129-140.
34. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999 ; 56: 303-308.
35. Salmon DP, Thomas RG, Pay MM, et al. Alzheimer's disease can be accurately diagnosed in very mildly impaired individuals. Neurology. 2002 ; 59: 1022-1028.
36. Rozzini L., Chilovi BV, Bertoletti E., et al. Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment. Int J Geriatr Psychiatry. 2006 ; 21: 550-555.
37. Rozzini L., Vicini Chilovi B., Delrio I., et al. Conversion of amnestic Mild Cognitive Impairment to Dementia of Alzheimer type is independent from memory deterioration. Int J Geriatr Psychiatry. 2007 ; 22: 1217-1222.
38. Purser JL, Fillenbaum GG, Pieper CF, Wallace RB Mild Cognitive impairment and 10-year trajectories of disability in the Iowa Established Populations for Epidemiologic Studies of the Elderly cohort. J Am Geriatr Soc. 2005 ; 53: 1966-1972.
39. Ihl R., Frolich L., Dierks T., Martin EM, Maurer K. Differential validity of psychometric tests in dementia of the Alzheimer type. Psychiatry Res. 1992 ; 44: 93-106.
40. Morgan CD, Baade LE Neuropsychological testing and assessment scale for dementia of the Alzheimer's Type. Psychiatr Clin North Am. 1997 ; 20: 25-43.
41. Chen P., Ratcliff G., Belle SH, Cauley JA, DeKosky ST, Ganguli M. Cognitive tests that best discriminate between presymptomatic AD and those who remain non-demented. Neurology. 2000 ; 55: 1847-1853.